StockData
Edesa Biotech, Inc. logo

Edesa Biotech, Inc. (EDSA) stock

EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$2.06+0.10 (+5.10%)

Close on Nov 18, 2026Market cap $19.86MP/E –Yield –

Edesa Biotech revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Edesa Biotech's revenue for the twelve months ending Sep 30, 2021 was $0, down 100.0% year over year. For fiscal 2021 it was $0, down 100.0% from the year before. The highest annual figure on record is $1.27M in fiscal 2016.

Annual revenue

PeriodPeriod endValueChange
FY2021Sep 30, 2021$0-100.0%
FY2020Sep 30, 2020$328.80K+55.2%
FY2018Sep 30, 2018$211.85K-7.2%
FY2017Sep 30, 2017$228.29K-82.0%
FY2016Sep 30, 2016$1.27M+241.7%
FY2014Aug 31, 2014$372.13K-31.8%
FY2013Aug 31, 2013$545.47K+90.7%
FY2012Aug 31, 2012$286.05K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2021CQ3 2021Sep 30, 2021$0-100.0%
Q3 FY2021CQ2 2021Jun 30, 2021$0-100.0%
Q2 FY2021CQ1 2021Mar 31, 2021$0-100.0%
Q1 FY2021CQ4 2020Dec 31, 2020$0-100.0%
Q4 FY2020CQ3 2020Sep 30, 2020$5000.0%
Q3 FY2020CQ2 2020Jun 30, 2020$109.99K–
Q2 FY2020CQ1 2020Mar 31, 2020$110.52K–
Q1 FY2020CQ4 2019Dec 31, 2019$107.80K+98.7%
Q3 FY2019CQ2 2019Jun 30, 2019$500–
Q2 FY2019CQ1 2019Mar 31, 2019$0-100.0%
Q1 FY2019CQ4 2018Dec 31, 2018$0-100.0%
Q4 FY2018CQ3 2018Sep 30, 2018$54.26K+1783.9%
Q3 FY2018CQ2 2018Jun 30, 2018$0-100.0%
Q2 FY2018CQ1 2018Mar 31, 2018$64.05K+1.6%
Q1 FY2018CQ4 2017Dec 31, 2017$20.49K-85.6%
Q4 FY2017CQ3 2017Sep 30, 2017$2.88K-99.0%
Q3 FY2017CQ2 2017Jun 30, 2017$20.53K–
Q2 FY2017CQ1 2017Mar 31, 2017$63.02K–
Q1 FY2017CQ4 2016Dec 31, 2016$141.86K–
Q4 FY2016CQ3 2016Sep 30, 2016$276.10K–

More Edesa Biotech figures

See a number that looks wrong?